EU plans for better access to low-cost generics and biosimilars in new pharmaceutical strategy
The EU Commission wants to give Europeans more affordable and more accessible medicines, and then the European pharmaceutical industry needs to be strengthened and the safety of the supply chains needs to be top-notch next time we face a pandemic.
BY LOUISE WENDT JENSEN, TRANSLATED BY NIELSINE NIELSEN
An anthropocentric strategy.
Read this article for free
Register with your E-mail. No credit card required.